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1. Introduction 
The 15 hydroxy prostaglandin dehydrogenase 
(PGDH) catalyses the oxidation of the 15 (S) OH of 
prostaglandins to a 15 keto group [ 1,2] . This is 
known to be of considerable importance for the 
inactivation of these compounds in vivo [2-51. 
PGDH activity was first demonstrated in lung [2,6,7] , 
then in other tissues of many animals [8,9]. 
First attempts at purifying the PGDH were carried 
out on lungs [ 1,101 . More recently partial purification 
of the placental PGDH [ 1 l-l 31 and of the kidney 
PGDH [ 141 were reported. We describe here a method 
which enables us to obtain milligram amounts of this 
enzyme from human placenta with a high specific 
activity. This relative large scale purification will 
afford us to perform structural studies of this protein. 
2. Materials and methods 
2.1. Buffers 
Buffer I: 0.03 M potassium phosphate pH 7.2, 20% 
glycerol, 0.001 M EDTA. Buffer II: same buffer but 
0.15 M phosphate. Buffer III: 0.01 M potassium phos- 
phate, pH 7.2,20% glycerol, 0.001 M EDTA, 0.01 M 
fi-mercaptoethanol. Buffers IV, V, VI are the same as 
buffer III but with respectivly 0.03 M, 0.0 1 M, 0.15 
M phosphate. Buffer VII: 0.1 M sodium pyrophosphate, 
pH 9.2. 
2.2. Preparation of placental supernatant fraction 
The fresh placentas (less than one hour after deliv- 
ery) were homogenized (Ultra-Turrax) in 2 vol of 
204 
buffer I. The homogenate was centrifuged (20 000 g 
for 30 min) and the supernatant was used for purifi- 
cation. 
2.3. Purification method 
Unless otherwise stated, all operations were carried 
out at 4°C. The three first steps of the purification 
procedure were the same for PGDH and 17/3-oestradiol 
dehydrogenase (17@EaDH). 
Automatic DEAE cellulose chromatography 
(Whatman DE 23): the apparatus was assembled and 
perfected in the laboratory [ 1.51. Elution was carried 
out with a linear gradient obtained with buffer I and 
buffer II. Hydrophobic affinity chromatography: the 
preparation of the oestrone amino caproate Sepharose 
column and elution (buffer containing ammonium sul- 
phate) have been already described [ 161 for the puri- 
fication of the 17&EzDH. Second DEAE-cellulose 
chromatography (Whatman DE 32): elution was per- 
formed with a linear gradient of buffer IV and V. 
Hydroxy-apatite chromatography: (Biorad hydroxy- 
apatite). Columns (5 X 1.5 cm) were equilibrated in 
buffer III and elution was performed with two suc- 
cessive linear gradients: respectivly buffer III and 
buffer IV, buffer V and buffer VI. Third DEAE- 
cellulose chromatography (Whatman DE 32). Same 
conditions that described above. 
2.4. Analytical methods 
Spectrometric enzyme assay: the reaction cuvettes 
(1 cm light path), kept at 4”C, contained 0.6 Ctmole of 
NAD, 55 nmoles of substrate, 10 to 100 I.tlitre of en- 
zyme solution, and buffer VII to a final volume of 1 
ml. All the substrates used for kinetic studies were 
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racemic synthetic prostaglandins: the substrate used 
for ‘routine work’ 10,l 1-dihydroprostaglandin AZ 
(dihydro PGA2) and PGAz were graciously given by 
Roussel-Uclaf. All other prostaglandins were generous- 
ly supplied by Dr John E. Pike, of Upjohn Co. 
Concentration of proteins by ammonium sulphate 
precipitation or by ultrafiltration (Diaflo membrane) 
were already described for the liver 17/I-hydroxy-steroid 
dehydrogenase [171. The method of Ornstein and 
Davis [ 181 was used for analytical polyacrylamide gel 
electrophoresis, that of Weber and Osborn [ 191 for 
polyacrylamide gel electrophoresis in sodium dodecyl- 
sulphate (SDS), The enzymatic activity staining was 
performed according to Latner [20]. The molecular 
weight was determined by polyacrylamide gel electro- 
phoresis with different acrylamide concentration (meth- 
od of Hedrick and Smith [2 l] ) and by SDS polyacryl- 
amide gel electrophoresis. 
2.5. Amino acid analysis 
The protein was hydrolysed under vacuum by 6 N 
HCl during 24 hr at 110°C and analysed with a Beckman 
Multichrom auto analyser. 
3. Results 
3.1. Purification 
Table 1 summarises the purification procedures and 
the results. A 3000- to SOOO-fold purification was 
achieved with a 5% yield. The highest specific activity 
obtained was 2500 mUI/mg. Each purification was 
carried out with 4 to 8 placentas and gave 2 to 4 mg 
of protein. Separation of 17&E2DH and PGDH was 
achieved only after hydroxy-apatite chromatography. 
The 17/I-E,DH was eluted with the first gradient and 
the PGDH with the second. 
After analytical polyacrylamide gel electrophoresis, 
specific enzymatic staining showed one or two PGDH 
bands (depending of the batch of enzyme) which were 
both revealed by all the substrates used (either dihydro 
PGAZ, PGFzp, or PGE r). Relative migration of these 
two isozymic bands in gel of different acrylamide 
concentration showed that they have the same mole- 
cular weight. Graphic determination of their mol. wt. 
gave a value of 50 to 55 000. Protein staining showed 
a slower band, very thin which has been identified to 
the 17@EzDH and which represents less than 10% of 
the total protein. 
Table 1 
Purification of the placental PGDH 
Activity, 
mIU 
Protein, 
mg 
Specific 
activity, 
mIU/mg 
Yield, 
% 
Purification, 
X-fold 
Homogenate 9000 1500 0.6 
Automatic DEAE 
cellulose 6300 525 12 70 20 
(Whatman 23) 
Hydrophobic 
affinity 4797 41 117 54 195 
chromatography 
DEAE-cellulose 
(Whatman 32) 2350 12 195 26 325 
Hydroxy-apatite 1175 1.2 979 13 1631 
DEAE-cellulose 
(Whatman 32) 576 0.3 1866 6 3110 
1mlU = 1 nmole oxidized substrate per minute. Purification was carried out with 3 to 
6 placenta. Protein values were calculated for one placenta. 
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3.2. Stability 
Enzymatic solutions in buffer containing 2% 
glycerol and 10m2 M /3-mercaptoethanol lost only 1% 
of their activity after two days at 4°C. They could be 
stored at -24°C for one month with less than 2% 
loss of activity. 
The Km for NAD was 5 . lo-‘. The Km for dihydro 
PGAa was independent from NAD concentration in 
the range of 4 to 12 Km. 
3.4. Inactivation by thiol reagent 
3.3. Kinetic constants 
Kinetic constants obtained with different substrates 
and inhibitors are given in tables 2 and 3. The best 
substrates were PGEi , PGE2 and dihydro PGA2. The 
15methyl PGE2 was not substrate and had a Ki of 
6.4 . 1 0b4 M. The inhibition was of the competitive 
type. Methylation of the carboxylic function of PGA2 
prevented the oxidation of the substrate by the PGDH 
and decreases highly its affinity. Inhibition by this 
methyl ester is of mixed type (Ki = 16 . 10d4M). 
Oestrone and progesterone had an inhibitory effect 
on the PGDH at a concentration of 5 . 1 O-‘M. Inhibi- 
tion is competitive for the progesterone (Ki = 5.1 Oe5 M) 
and seems to be of mixed type for the oestrone 
(Ki = 10T4M). The enzyme was strictly NAD-dependent. 
4. Discussion 
The enzyme was completly inactivated by 5 . lo-’ M 
Ellman’s reagent and by 5 . 10s4M phenyl mercury 
acetate. Inhibition by 5 . lo-‘M Ellman’s reagent was 
prevented by addition of 3 . IO-‘M NAD or 2.7 . 
10e6 M dihydro-PGAi-:The inactivation of the PGDH 
by 5 . 10e4 M phenyl mercury acetate was partly 
reversed by fi-mercaptoethanol(50% of the initial 
activity were recovered whatever could be the duration 
of incubation with the inhibitor). 
17fl-E2DH. These two enzymes were very difficult to 
separate with preservation of the PGDH activity: 
In the present study a 3000- to 5000-fold purifica- 
tion of the human placental PGDH was achieved. In 
the best conditions, when the enzyme had a specific 
activity of 2500 mUI/mg, it still contained traces of 
Table 2 
Substrate* specificity of the placental PGDH 
Substrate Km 
/JM. 
Relative Vmax 
(p. 100 of PGE,) 
Prostaglandin E, 2.9 100 
Prostaglandin E, 4.0 91 
Prostaglandin F, o 57.0 91 
Prostaglandin F,, 26.3 97 
Prostaglandin A, 8.7 109 
Prostaglandin A, 50.0 24 
lO,ll-dihydro PGA, 4.5 111 
* All substrates used are racemic compounds. 
Table 3 
Inhibition of placental PGDH by different prostaglandins 
derivatives and by steroids 
Substrate Ki M 
15 methyl PGF,, 6.4 . lo-’ 
PGA, methyl ester 1.6 . lo-’ 
Progesterone 7. 1o-5 
Oestrone lo-’ 
Type of inhibition 
competitive 
mixed 
competitive 
mixed (?) 
Both PGDH and 1 7/3-E2DH were retained on 
oestrone Sepharose columns. This unexpected result 
can be explained, either by the affinity of the PGDH 
for oestrone (which is an inhibitor of the enzyme: 
Ki = 10e4M) or by eventual hydrophobic interactions 
occurring in the presence of ammonium sulphate bet- 
ween the 17fl-E2 DH retained on the phase and the 
PGDH [22]. 
Separation by gel filtration on Sephadex columns 
was only partially effective due the small difference 
between the molecular weight of these two enzymes, 
and had a poor yield in PGDH due to its lability. The 
greater lability of the PGDH when compared to the 
17/3-E2DH facilitated on the contrary the 17/3-E2DH 
purification: 17/3-E2DH solutions were easily rid of 
the PGDH by handling the material at room temperature 
and by using buffers without /.I-mercaptoethanol. Never- 
theless a good separation of PGDH from 17/3-EaDH was 
achieved by hydroxy-apatite chromatography. Evidence 
of this separation was given by the amino acid analysis 
of the purified PGDH which showed an amino acid com- 
position different from that of the 1 7P-E2 DH, especially 
in methionine percentage. 
From the yield of the purification procedure describ- 
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ed above it can be calculated that each placenta (300 g) 
contains about 5 to 10 mg of PGDH. It is at the present 
time the richest source of PGDH known: purification 
from lungs gave very poor yields; the best results are a 
1 S-fold purification with a 45% yield and specific 
activity 4 nmoles/min/mg [ 10,221 .
Two bands of PGDH activity were often seen on 
polyacrylamide gel; this finding, which is not constant, 
was also reported by Schlegel [ 121. The behaviour of 
these bands in gels of increasing acrylamide concentra- 
tion gives evidence that they have the same mol. wt. 
(50 - 55 000). Mol. wt. values determined by SDS 
polyacrylamide gel electrophoresis were a little lower 
42 000. This result is in good agreement with the mol. 
wt. of 44 000 given recently for placental PGDH by 
Braithwaite and Jarabak [ 131 .
Our kinetic data showed that the K, for PGE, , 
PGEZ , PGAi and dihydro PGAz are in the 10e6 M 
range. These values and the corresponding Vmax are 
in good agreement with those of Jarabak [ 111 but 
quite different from those recently reported by 
Schlegel [ 121. This discrepancy cannot be related to 
a difference in pH conditions of kinetic measurements, 
for pH conditions were also different in Jarabak’s 
experiments, who yet reported similar K, values. 
However, such a difference could be explained by the 
low NAD concentration (1 . 1 O-‘M, lower than K,) 
used by Schlegel, or by differences in molecular forms 
induced by different methods of purification as suggest- 
ed by this autor. These molecular forms, or the pre- 
sence of contaminating inhibitor(s) in the substrate, 
might also explain the different Vmax values given for 
PGFaa by Schlegel. 
The kinetic behaviour of the dihydro PGAa is quite 
interesting. PGAa is not a good substrate but suppres- 
sion of the 10,ll double bond highly increases the 
affinity of this substrate for the enzyme. The relativly 
low K, of PGF may have physiological and pharma- 
cological incidences. 
When comparing the affinity of the placental PGDH 
for its substrates to PGDH of other organs, affinity of 
the same order of magnitude (1 0T6 M) is found for the 
placental and the kidney PGDH and a little lower 
(lo-‘M) for the lung PGDH. 
Inhibition of PGDH by steroids was investigated 
by Schlegel [ 121 on very crude enzymatic preparations. 
The inhibitory effect of progesterone and oestrone 
reported in this present work on purified PGDH was 
effective at only very high concentrations of steroid 
(1 O-’ M) and the type of inhibition is not clearly deli- 
nite in the case of oestrone. 
Whether regulation of PGDH by these hormones 
is of physiological importance awaits further experi- 
ments with very low concentrations of both prosta- 
glandins and steroids. 
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